Michael Rossi: Advancing Clinical Cancer Research With NGS


Michael Rossi, Phd discusses the important role of next-generation sequencing (NGS) in clinical cancer research. www.illumina.com/cancer Dr. Rossi explains how NGS enables researchers to cost-effectively assess multiple genes in a single test. He emphasizes partnership with pathologists and concludes by encouraging newcomers to make the move to NGS to accelerate progress in clinical cancer research. Presenter: Michael Rossi PhD, Assistant Professor, Department of Radiation Oncology, Emory University School of Medicine Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc View other cancer genomics videos https://www.youtube.com/playlist?list=PLKRu7cmBQlaiQbVkCco7Kre3KkyElP04h View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina product videos https://www.youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM